Covance appoints Vice President Corporate Communications.PRINCETON, N.J.--(BW HealthWire)--April 23, 1997--Covance Inc. (NYSE NYSE See: New York Stock Exchange : CVD CVD Cardiovascular disease, see there ) announced that Beth Leahy has joined the company as Vice President Corporate Communications Corporate communications is the process of facilitating information and knowledge exchanges with internal and key external groups and individuals that have a direct relationship with an enterprise. . Ms. Leahy will serve as the company's principal communications officer and will be its media spokesperson. Prior to joining Covance, Ms. Leahy was Vice President Communications and Public Affairs Those public information, command information, and community relations activities directed toward both the external and internal publics with interest in the Department of Defense. Also called PA. See also command information; community relations; public information. for Centeon L.L.C., a subsidiary of Rhone-Poulenc Rorer, Inc. Prior to her promotion to Centeon, she worked for Rhone-Poulenc Rorer for over ten years in positions of increasing responsibility. She began her business career at Dow Jones and Company (The Wall Street Journal). She graduated with honors in accounting and communications from the University of Scranton The University of Scranton is a private, co-educational Jesuit university, located in Scranton, Pennsylvania, in the northeast region of the state. The school was founded in 1888 by Most Rev. William O'Hara, the first Bishop of Scranton, as St. Thomas College. and continued graduate studies in business at Drexel University. She is also a certified public accountant Certified Public Accountant (CPA) An accountant who has met certain standards, including experience, age, and licensing, and passed exams in a particular state. in the state of New Jersey. Covance, with headquarters in Princeton, N.J., is one of the world's largest and most comprehensive biopharmaceutical development service companies, with 1996 revenues of approximately $495 million, operations currently in more than 16 countries, and more than 5,500 employees worldwide. Covance combines superior development experience, expertise and global presence to provide preclinical, health economics, central laboratory, biomanufacturing, clinical packaging, and clinical and periapproval services to the world's pharmaceutical, biotechnology and medical device companies. CONTACT: Beth Leahy, Media: 609/452-4978 or Parag Bhansali, Investor Community: 609/452-4953 |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion